CD8A and neoplasm: In recent studies, tumor-infiltrated lymphocytes, particularly CD8 + and NK cells, have been shown to constitute a better indicator of tumor recurrence than the American Joint Committee on Cancer (AJCC) / International Union Against Cancer (UICC) - TNM staging (Mlecnik et al., 2011).